– CHINA, Hong Kong – Jardine Matheson Holdings Limited (LON: JAR) today announced the appointment of Dr. Keyu Jin (Ph.D.) to its Board as an Independent Non-Executive Director effective from 31st January 2024.
“I would also like to welcome Keyu to the Board, which will benefit from her extensive expertise and experience,” said Board Chairman, Ben Keswick.
The company also announced that Anthony Nightingale will step down from the Board with effect from 31st January 2024, while YK Pang and David Hsu will step down from the Board with effect from 31st March 2024.
About Dr. Keyu Jin
Dr. Keyu Jin is a tenured professor of Economics at the London School of Economics and Political Science, where she researches globalization and the Chinese economy. She is from Beijing, China, and holds a B.A., M.A., and a PhD from Harvard University.
Keyu is an independent non-executive director of Compagnie Financière Richemont SA, the second-largest luxury conglomerate, AInnovation, an AI+ manufacturing solution provider, and of Stanhope Capital, one of the world’s largest independent wealth management and advisory firms. Keyu is a member of China Finance 40 and a member of the economic council for the state of Qatar. She has previously advised and consulted for the World Bank, the IMF, and the New York Fed.
Anthony Nightingale
Anthony Nightingale joined the Jardines Group in 1969 and was appointed as a Director of the Company in 1994. He was Managing Director from 2006 until he retired from executive office in 2012. Anthony is also a director of DFI Retail Group Holdings Limited and Hong Kong Land Holdings Limited, and he will step down from these boards and from his position as Chairman and member of the DFI Audit Committee on 31st January 2024.
SOURCE: https://www.jardines.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.